Weekly Medical Podcast Reviews Sepsis Care, Hormone Risks, and Cancer Screening
This episode of TTHealthWatch examines several recent medical studies, including approaches to treating early septic shock and the relationship between menopausal hormone therapy and thromboembolic events. It also discusses blood-based screening for multiple cancers and lean metabolic dysfunction-associated steatotic liver disease. The podcast is hosted by Elizabeth Tracey and Rick Lange.
The podcast reviews a multinational retrospective study of biopsy-confirmed lean MASLD, involving more than 18,000 adults across 41 countries. Roughly 6–7% had lean disease, with less type 2 diabetes and less advanced fibrosis; mortality tracked with fibrosis severity. Elastography was more accurate than FIB-4 for assessing fibrosis in this group.
Other segments cover menopausal hormone therapy and thromboembolic events, including VTE, ischemic stroke, and MI, with oral estrogen linked to higher risk. Blood-based multi-cancer screening showed no clear benefit versus routine screening, and early septic shock strategies produced similar day-90 survival out of hospital.
These findings may inform conversations among patients and clinicians about liver fibrosis assessment, hormone therapy choices, cancer screening expectations, and early sepsis care. People with lean MASLD could benefit from better recognition, while those weighing menopausal hormones may consider clot and cardiovascular risks. Health systems may use such evidence to refine screening and treatment protocols, though podcast summaries alone cannot replace clinical guidance or shared decision-making.